These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5037436)

  • 21. Effect of DL-sodium lactate infusion on excretion of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):588-92. PubMed ID: 8314359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary excretion of purine and pyrimidine metabolites in the neonate.
    Van Acker KJ; Eyskens FJ; Verkerk RM; Scharpé SS
    Pediatr Res; 1993 Dec; 34(6):762-6. PubMed ID: 8108189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of purine-free low-malt liquor (happo-shu) on the plasma concentrations and urinary excretion of purine bases and uridine--comparison between purine-free and regular happo-shu.
    Yamamoto T; Moriwaki Y; Ka T; Inokuchi T; Takahashi S; Tsutsumi Z; Fukuchi M; Hada T
    Horm Metab Res; 2004 Apr; 36(4):231-7. PubMed ID: 15114522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays.
    Hedvat CV; Jaffe ES; Qin J; Filippa DA; Cordon-Cardo C; Tosato G; Nimer SD; Teruya-Feldstein J
    Mod Pathol; 2001 Dec; 14(12):1270-6. PubMed ID: 11743050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postchemotherapy purine excretion in lymphoma patients receiving allopurinol.
    Hande KR; Hixson CV; Chabner BA
    Cancer Res; 1981 Jun; 41(6):2273-9. PubMed ID: 7237428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary excretory patterns of tRNA degradation products: a marker of Hodgkin's cell metabolism?
    Cooper IA; Wray GR; Murphy TL
    Eur J Cancer (1965); 1977 Nov; 13(11):1309-12. PubMed ID: 590288
    [No Abstract]   [Full Text] [Related]  

  • 27. Hodgkin's disease (retrospective study of 119 cases).
    Vashisht S; Aikat BK
    Indian J Cancer; 1973 Sep; 10(3):263-79. PubMed ID: 4785877
    [No Abstract]   [Full Text] [Related]  

  • 28. Detailed comparison of the urinary excretion of purines in a patient with the Lesch-Nyhan syndrome and a control subject.
    Sweetman L; Nyhan WL
    Biochem Med; 1970 Sep; 4(2):121-34. PubMed ID: 5134918
    [No Abstract]   [Full Text] [Related]  

  • 29. Is multiple lymph node biopsy essential during staging laparotomy for Hodgkin's disease?
    Miller D; Gillett R; Irving MH
    Clin Oncol; 1980 Mar; 6(1):49-53. PubMed ID: 7371236
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolism of aminonucleoside-8-14C in the rat and guinea pig.
    Nagasawa HT; Swingle KF; Alexander CS
    Biochem Pharmacol; 1967 Nov; 16(11):2211-9. PubMed ID: 6076611
    [No Abstract]   [Full Text] [Related]  

  • 31. THE DYE-SENSITIZED PHOTOOXIDATION OF PURINE AND PYRIMIDINE DERIVATIVES.
    SIMON MI; VANVUNAKIS H
    Arch Biochem Biophys; 1964 Apr; 105():197-206. PubMed ID: 14165495
    [No Abstract]   [Full Text] [Related]  

  • 32. Interfollicular Hodgkin's disease: an uncommon pattern that may cause diagnostic difficulty.
    Basu D; Roy SK
    Indian J Pathol Microbiol; 2006 Apr; 49(2):221-5. PubMed ID: 16933719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term study of four cases of lymphadenopathy terminating into Hodgkin's disease.
    Mukherjee AM; Khan KP
    Bull Calcutta Sch Trop Med; 1970 Oct; 18(4):105-7. PubMed ID: 5527138
    [No Abstract]   [Full Text] [Related]  

  • 34. Transfer RNA and transfer RNA methylase activity in spleens of patients with Hodgkin's disease and histiocytic lymphoma.
    Murphy TL; Cooper IA; Wray GW; Ironside PN; Matthews J
    J Natl Cancer Inst; 1976 Feb; 56(2):215-9. PubMed ID: 768501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isotachophoresis of urinary purines and pyrimidines: the use of spacers and enzymes for identification.
    Oerlemans F; de Bruyn C; Mikkers F; Verheggen T; Everaerts F
    J Chromatogr; 1981 Oct; 225(2):369-79. PubMed ID: 7298771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observer disagreement in the classification and histology of Hodgkin's disease.
    Coppleson LW; Factor RM; Strum SB; Graff PW; Rappaport H
    J Natl Cancer Inst; 1970 Oct; 45(4):731-40. PubMed ID: 5513500
    [No Abstract]   [Full Text] [Related]  

  • 37. [Letter: Hypouricemia in Hodgkin's disease].
    Vernant JP; Zittoun R
    Nouv Presse Med; 1975 Sep; 4(29):2111. PubMed ID: 1178465
    [No Abstract]   [Full Text] [Related]  

  • 38. Chromosome changes in Hodgkin's disease.
    Seif GS; Spriggs AI
    J Natl Cancer Inst; 1967 Sep; 39(3):557-70. PubMed ID: 6053720
    [No Abstract]   [Full Text] [Related]  

  • 39. Histopathologic and immunocytochemical study of Hodgkin's disease.
    Choi SI; Kim KR; Jeong HJ; Park CI; Choi IJ
    Yonsei Med J; 1988; 29(4):326-32. PubMed ID: 3072781
    [No Abstract]   [Full Text] [Related]  

  • 40. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
    Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
    Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.